Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

153.31 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Mar 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Johnson & Johnson

< Previous 1 2 3 4 5 6 Next >
Baby Health and Personal Care Market May See a Big Move : Johnson & Johnson, Danone, Pigeon
NJ New Jersey, USA -- (SBWIRE) -- 03/28/2023 -- Advance Market Analytics published a new research publication on "Baby Health and Personal Care Market Insights, to 2028" with 232 pages and enriched... 
Via SBWire
Exposures Textiles
New Regional Director for EMEA to Drive Next Stage of Growth Across the Region for Jeron Nurse Call Systems
NILES, Ill. - March 24, 2023 - PRLog -- Jeron Electronic Systems, Inc. announced today that Dr. Ahmed Adel MBA-MDS has joined the Jeron sales team as the Regional Director for the EMEA. In this newly... 
Via PRLog
Topics Economy
Exposures Supply Chain
Johnson & Johnson (NYSE: JNJ) is Today’s Stock Spotlight
Via Investor Brand Network
What Is Autologous Cell-Based Therapy, The Treatment Revolutionizing Regenerative Medicine That Could Be Set To Explode Over The Next Few Years?
By Julian Richard, Benzinga 
Via TheNewswire.com
Exposures Product Safety
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
From Johnson & Johnson
Via Business Wire
Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature
From Johnson & Johnson
Via Business Wire
Healthcare Stocks With at Least 30 Years of Dividend Increases
Among the many industry sectors to invest in, healthcare can be one of the most stable, especially regarding the dividend yield. 
Via MarketBeat
3 Large Cap Dividend Challengers for Millennial Investors
Dividend Challengers may be the perfect match for Millennials and other younger investors whose dividend growth journey has only just begun. 
Via MarketBeat
10 Best Consumer Staples ETFs
Consumer staples ETFs may offer trading flexibility, portfolio diversification and tax benefits. Check out the best consumer staples ETFs. 
Via MarketBeat
Topics ETFs Stocks
Exposures US Equities
Johnson & Johnson Announces Pricing of $7.75 Billion of Senior Notes Issued by Kenvue Inc.
From Johnson & Johnson
Via Business Wire
How to Pick the Best Dividend Stocks
A stock’s dividend yield is a key metric for investors, so what is a good dividend yield? We’ll explore the answer in this article. 
Via MarketBeat
Topics Economy
Exposures Interest Rates
What Are Blue Chip Stocks? An Overview of Blue Chips
Blue chip stocks come from stable, established companies that are usually household names. Learn more about blue chip stocks with MarketBeat. 
Via MarketBeat
Topics Stocks
Exposures US Equities
Lucy Scientific Discovery, Inc. Scores Major Milestone, Transitions To Revenue Generating Company With First Commercial Sale Of Psilocybin ($LSDI)
Via AB Newswire
Is Amazon a Blue Chip Stock?
Is Amazon a blue chip stock or does it fit into a different category? Learn more about Amazon.com Inc. and how to categorize it with MarketBeat. 
Via MarketBeat
What Are Dividend Payment Dates?
What are dividend payment dates? The payment date is the day a company pays its eligible shareholders dividends. Learn more. 
Via MarketBeat
Johnson & Johnson: Taking The Bull By The Horns?
Johnson & Johnson is rushing toward a patent cliff but a new shelf offering registration suggests itis gearing up for acquisitions. 
Via MarketBeat
Topics Intellectual Property Regulatory Compliance
Exposures Intellectual Property Legal Regulatory
Johnson & Johnson Names Paula A. Johnson, President of Wellesley College, to its Board of Directors
From Johnson & Johnson
Via Business Wire
Johnson & Johnson to Participate in the Barclays Global HealthCare Conference
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&D
From Johnson & Johnson
Via Business Wire
Pain Relief Medication Market to Witness Huge Growth by Key Players: Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Sanofi S.A., GlaxoSmithKline Plc.
Global Pain Relief Medication Market By Material (Acute, Chronic), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) 
Via SBWire
MarketBeat Week in Review – 1/30 - 2/3
The markets are trending lower to end the week. It’s hard to figure out the markets after the blockbuster job report, but the MarketBeat team gave it a shot 
Via MarketBeat
Topics Artificial Intelligence Earnings Economy
Exposures Artificial Intelligence Financial Interest Rates
Johnson & Johnson to Participate in the Cowen 43rd Annual HealthCare Conference
From Johnson & Johnson
Via Business Wire
Liposome Drug Delivery Market 2023 in-Depth Analysis, Growth, Size, Future Prospect, Regional Development and Global Outlook 2029
Liposome Drug Delivery Market Size, Share and Forecast 2023-2029 Key Players are – Ipsen Pharma, Celsion Corp, Gilead Sciences, Astellas Pharma, Johnson & Johnson, Luye Pharma Group, Novartis AG 
Via SBWire
Exposures COVID-19
Rancho Biosciences Welcomes BenevolentAI as New Member to Its Single Cell Data Science Consortium
SAN DIEGO, February 1, 2023 (Newswire.com) - On Feb. 26, 2022, Rancho Biosciences, a leading data sciences services company, launched its Single Cell Data Science (SCDS) pre-competitive consortium,... 
Via Newswire.com
How Do Lawsuits Affect Johnson & Johnson's Stock Price?
JNJ's stock price was hit hard on Monday following the court's ruling for billions of dollars worth of lawsuits - what does this mean for investors? 
Via MarketBeat
Topics Bankruptcy Lawsuit
Exposures Financial Legal
Osteotomy Plates Market Share with Top Countries Data, Size, Global Industry Challenges, Business Overview and Forecast Research Study 2028
Osteotomy Plates SWOT Analysis Including Key Players - Arthrex, Acumed, Medartis, Johnson & Johnson, Group Fh Ortho, B. Braun Melsungen, Zimmer Biomet, Stryker Corporation, aap Implantate, Wright... 
Via SBWire
Topics Supply Chain
Exposures Supply Chain
Two Dividend Kings: Johnson & Johnson or Abbott Laboratories?
Johnson & Johnson and Abbott Laboratories are 2 dividend kings guiding for growth in 2023 and are on track to increase their yield yet again. 
Via MarketBeat
Topics Economy
Exposures Interest Rates
How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
Five biotechs have already issued layoffs in 2023. Many seem to have good potential, but time will tell if the shifts create the value analysts anticipate. 
Via MarketBeat
Topics Workforce
Exposures Layoff Product Safety
Johnson & Johnson Reports Q4 and Full-Year 2022 Results
From Johnson & Johnson
Via Business Wire
MarketBeat Week in Review – 1/16 - 1/20
The shortened trading week looks to be ending on a sour note over growing recession fears. Here are some of the top stories from our MarketBeat contributors 
Via MarketBeat
Topics Economy Workforce
Exposures Economy Layoff
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.